Gallium works with scientist in “emerging technologies”,
science-based innovations with the potential to create a new industry
or transform an existing industry at an astonishing speed.
With these technologies the risks and uncertainties
are greatest and traditional business strategies are most likely to fail.
Gallium avoids over hyping the opportunity and focuses on achieving realizable
targets. Gallium identifies IF and HOW a technology can be used to solve
identifiable and quantifiable pain for existing and targetable customers.
Emerging technologies are often complex combinations
of different technologies, from different scientific areas and can orginate
in different industries. For example genomics is evolving around medicine,
biology, chemistry, micro electronics and computer science. New terms
like bioinformatics are invented to identify combinations of expertise.
For these emerging technologies
it is initially unclear is what products and services will be most
successful, what companies will enter the market and for what existing
the technology is most valuable. These questions are answered during
the development of the technologies.
Emerging industries are further challenged by a
lack of existing companies in that field and established market leaders
industries often overlook the potential.
Gallium joins forces with the
scientists to create new technology firms (spin offs, joint ventures)
or position the technology
such that market leaders in related industries are convinced of the
Scientists can tap into Gallium while Gallium can interact
with the scientist to define the real potential and create a
successful technical and commercial development path.